MedTrace Logo

Ten Fraction Adjuvant Hypofractionated Radiotherapy in Node Positive Breast Cancer

NCT04792346 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 61

Last updated 2021-03-10

No results posted yet for this study

Summary

Post-operative loco-regional (LR) hypofractionated radiotherapy (Hypo-RT) is an attractive approach in locally advanced breast cancer (LABC).

Conditions

Interventions

RADIATION

breast/chest wall radiotherapy

34 Gy/10 fxs/2 wks to the whole breast/chest wall and locoregional lymph nodes; an optional single fraction 8 Gy boost was administered with electrons to the tumor bed in patients undergoing conservative surgery

Sponsors & Collaborators

  • Giuseppe Sanguineti

    collaborator UNKNOWN

  • Silvia Takanen

    collaborator UNKNOWN

  • Serena Nucciarelli

    collaborator UNKNOWN

  • Francesco Rulli

    collaborator UNKNOWN

  • Maria Papale

    collaborator UNKNOWN

  • Valeria Landoni

    collaborator UNKNOWN

  • Mauro Caterino

    collaborator UNKNOWN

  • Diana Giannarelli

    collaborator UNKNOWN

  • Ilaria Farina

    collaborator UNKNOWN

  • Paola Franzoso

    collaborator UNKNOWN

  • Regina Elena Cancer Institute

    lead OTHER

Principal Investigators

  • Paola Pinnaro · IFO

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2019-01-07
Completion
2021-03-02

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04792346 on ClinicalTrials.gov